PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer.

Abdelrahman Y SherifGamaleldin I HarisaFars K AlanaziFahd A NasrAli S Alqahtani

Published in: International journal of nanomedicine (2022)

These results concluded that GEF-P-SLN is a promising approach to improving the therapeutic outcomes of GEF in the treatment of metastatic lung cancer.

Keyphrases

small cell lung cancer
squamous cell carcinoma
epidermal growth factor receptor
radiation therapy
adipose tissue
combination therapy
insulin resistance
glycemic control
tyrosine kinase
recombinant human